Synaptogenix, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Synaptogenix, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2021 to Q2 2024.
  • Synaptogenix, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $308K.
  • Synaptogenix, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $5.12M, a 45.8% decline year-over-year.
  • Synaptogenix, Inc. annual Nonoperating Income (Expense) for 2023 was $2.28M, a 78.5% decline from 2022.
  • Synaptogenix, Inc. annual Nonoperating Income (Expense) for 2022 was $10.6M, a 148438% increase from 2021.
  • Synaptogenix, Inc. annual Nonoperating Income (Expense) for 2021 was $7.11K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $5.12M $308K +$2.57M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $2.55M $1.48M +$275K +22.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.28M $1.14M -$9.23M -89% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $11.5M $2.19M +$2.05M +1458% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $9.46M -$2.26M -$2.31M -5190% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $11.8M $1.21M +$1.21M +26151% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $10.6M $10.4M Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $141K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $44.5K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $4.61K +$3.79K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $816* Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.